Skip to main content

FDA approves Afluria flu vaccine

10/2/2007

AUSTRALIA The Food and Drug Administration has approved CSL’s flu vaccine Afluria, according to The Australian.

The company expects to ship two million doses as part of its first shipment to the U.S. between mid-December and early February. The company expects to increase its export to 20 million doses over the next four years.

“We’ve entered the US market quite late, but over the next few years we hope to increase our export of flu vaccine to the US to 20 million doses,” CSL’s Dr Rachel David said.

X
This ad will auto-close in 10 seconds